Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 80 citing STRAUS: Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed.... (0.11 sec) 

Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir


E Gluckman, A Devergie, R Melo, T Nebout, … - The Lancet, 1983 - Elsevier
In a double-blind controlled study, oral acyclovir was compared with placebo in
39 consecutive patients undergoing bone-marrow transplantation. Acyclovir was
given at a dose of 200 mg every 6 h from 8 days before to 35 days after ...
Cited by 104 - Related articles - All 6 versions

Successful treatment of progressive mucocutaneous infection due to acyclovirand foscarnet …


R Snoeck, G Andrei, A Silverman, A Hedderman … - Clinical Infectious Diseases, 1994 - jstor.org
Page 1. 570 Successful Treatment of Progressive Mucocutaneous Infection Due to
Acyclovir- and Foscarnet-Resistant Herpes Simplex Virus with (S)-1-(3-Hydroxy-2- ...
Cited by 97 - Related articles - BL Direct - All 4 versions

Cutaneous manifestations of immunosuppression in organ transplant recipients+++


EA Abel - Journal of the American Academy of Dermatology, 1989 - Elsevier
Skin disease is a significant cause of morbidity in chronically
immune-suppressed patients, including organ transplant recipients. Cutaneous
drug reactions may be caused by immunosuppressive therapy that commonly ...
Cited by 85 - Related articles - All 3 versions

Long-term suppression of recurrent genital herpes with acyclovir: a 5-year benchmark


LH Goldberg, R Kaufman, TO Kurtz, MA … - Archives of Dermatology, 1993 - archderm.highwire.org
\s=b\Background and Design.\p=m-\Thismulticenter trial (19 sites) was initiated
in 1984 in more than 1100 immunocompetent individuals with a history of
frequently recurring genital her- pes (mean, \m=ge\12episodes per year). ...
Cited by 82 - Related articles - BL Direct - All 4 versions

Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster …

- nih.gov [PDF] 
CL Talarico, WC Phelps, KK Biron - Journal of virology, 1993 - Am Soc Microbiol
JOURNAL OF VIROLOGY, Feb. 1993, p. 1024-1033 0022-538X/93/021024-10$02.00/0
Copyright X 1993, American Society for Microbiology ... Analysis of the
Thymidine Kinase Genes from Acyclovir-Resistant
Cited by 62 - Related articles - BL Direct - All 7 versions

[PDF] Chronic erosive herpes simplex virus infection of the penis, a possible immune …


PA Fox, SE Barton, N Francis, M Youle, DC … - HIV medicine, 1999 - hawaii.edu
Objective To report a novel clinical presentation: a chronic erosive herpes
simplex virus (HSV) infection of the penis which developed in AIDS patients
following the commencement of highly active antiretroviral therapy (HAART). ...
Cited by 58 - Related articles - View as HTML - BL Direct - All 4 versions

Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir


L Seale, CJ Jones, S Kathpalia, GG … - Jama, 1985 - Am Med Assoc
Forty patients with serum antibody against herpes simplex virus (HSV) were
enrolled in a randomized, placebo-controlled, double-blind investigation of
acyclovir given orally in a low dosage as prophylaxis against recurrent HSV ...
Cited by 45 - Related articles - All 3 versions

[CITATION] The pathology of bone marrow transplantation


GE Sale, HM Shulman, 1984 - Mosby
Cited by 44 - Related articles

Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the …

- nih.gov [PDF] 
SL Spruance, MB McKeough, JR Cardinal - Antimicrobial agents and chemotherapy, 1984 - Am Soc Microbiol
Page 1. Vol. 25, No. 1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1984,
p. 10-15 0066-4804/84/010010-06$02.00/0 Copyright C 1984 ...
Cited by 44 - Related articles - All 6 versions

Treatment of chronic non-A, non-B hepatitis with acyclovir: A pilot study


SC Pappas, JH Hoofnagle, N Young, SE … - J Med Virol, 1985 - interscience.wiley.com
Five patients with chronic non-A, non-B hepatitis were entered into a pilot
therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl)
guanine]. Each patient received acyclovir by slow intravenous infusion in a ...
Cited by 37 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google